Alerts will be sent to your verified email
Verify Email
BACPHAR
|
Bacil Pharma
|
Mercury Laboratories
|
Vaishali Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.32 % | 10.51 % | 7.83 % |
|
5yr average Equity Multiplier
|
1.36 | 1.49 | 2.48 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 1.05 | 0.88 |
|
5yr Avg Net Profit Margin
|
0.0 | 6.6 % | 3.68 % |
|
Price to Book
|
3.23 | 1.63 | 1.38 |
|
P/E
|
115.39 | 19.21 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -4.69 Days | 87.63 Days |
|
Inventory Days
|
0.0 | 32.68 Days | 6.87 Days |
|
Days Receivable
|
0.0 | 115.65 Days | 177.19 Days |
|
Days Payable
|
0.0 | 157.73 Days | 159.49 Days |
|
5yr Average Interest Coverage Ratio
|
-943.72 | 15.15 | 2.55 |
|
5yr Avg ROCE
|
-75.56 % | 13.49 % | 15.65 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 11.74 % | 5.99 % |
|
5 yr average Debt to Equity
|
0.05 | 0.13 | 0.48 |
|
5yr CAGR Net Profit
|
n/a | -10.08 % | -4.82 % |
|
5yr Average Return on Assets
|
-70.2 % | 7.02 % | 3.24 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 73.66 % | 31.61 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-42.67 % | 0.0 | 4.87 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bacil Pharma
|
Mercury Laboratories
|
Vaishali Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|